Scientific Protein Laboratories, LLC

Platypus Technologies, LLC

Karla Anhalt

Anisha Akula

Yan Wang

Dustin Nielsen

Dana Spangenberg

Mark Romich

Kenneth S Manning

Ryan Ruf

Carmen Fritz

Colin Crowley

Jon Restivo

Nicholas Lawrence Abbott

Christopher John Murphy

Barbara Israel

Bharat Raj Acharya

Doug Hansmann

Syrus Soltaninassab

A pancreatin preparation having reduced viral infectivity includes one or more pancreatin enzymes and peracetic acid (PAA). At least one pancreatin enzyme may be derived from an animal source such as a porcine pancreas gland. In a particular embodiment, the one or more pancreatin enzymes are selected from the group consisting of lipases, proteases, and amylases.

Method for reducing or inactivating viral and microbial content in the processes for the manufacture of pancreatin

A method for the reduction or inactivation of viral and microbial content in the manufacturing of pancreatin API is disclosed. The method includes treating animal-derived tissue with peracetic acid to reduce viral activity and bacterial load prior to processing. In particular, the method includes treating porcine pancreas glands with peracteic acid prior to extracting a pancreatin API from the treated glandular tissue.

The present invention relates to the field of detection of viruses, and in particular to detection of viruses using a liquid crystal assay format. In the present invention, virus binding in a detection region is identified by changes in liquid crystal orientation caused by virus binding independent orientation caused by any topography associated with the detection region.

Liquid crystal based analyte detection

Growing community of inventors

DeForest, WI, United States of America

Karla Anhalt